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Endoluminal repair of carotid artery
pseudoaneurysms: A word of caution
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This report describes our results with covered endoluminal stents in the management of 4 patients with carotid artery
pseudoaneurysms (PSAs) following carotid endarterectomy (CEA).
Two patients had symptomatic embolization of thrombus from the PSA’s into branches of the middle cerebral arteries
(MCA) during deployment of the stents. Endoluminal stents were deployed uneventfully in the other two. At 12 month
follow-up, one patient had an occlusion of the stent.
While endoluminal therapy of carotid PSAs in an effective method to exclude PSAs, embolization of thrombus is a
potential hazard. The long-term patency of covered stents in the carotid artery is unknown. (J Vasc Surg 2004;40:
1020-3.)Patch angioplasty is frequently used after carotid
endarterectomy (CEA) to minimize the risks of early
postoperative carotid artery thrombosis and late recur-
rent stenosis.1-3 Pseudoaneursym formation is a poten-
tial complication after carotid patch angioplasty.4-6 Re-
pair of pseudoaneurysm is usually required, because of
the potential for rupture and distal embolization, as they
often contain thrombus. In addition, pseudoaneurysm
may cause symptoms by compressing adjacent struc-
tures.5
Generally favorable results with endoluminal therapy
have been reported in the treatment of carotid artery aneu-
rysms and pseudoaneurysms as well as pseudoaneurysms in
other locations.4-18 These procedures are not without risk,
however, as reported by May et al,4 who described a patient
with stroke secondary to embolization of thrombus during
endoluminal repair of a carotid pseudoaneurysm. In this
patient the stent graft was thrombosed at 6-month follow-
up, despite the patient taking warfarin sodium (Couma-
din). We describe our results with endoluminal therapy
with covered stents in the treatment of pseudoaneurysm
after CEA in 4 patients.
METHODS
In May 2001 we began an institutional review board–
approved trial of Surgisis vascular patches (Cook Biotech)
in patients undergoing carotid patch angioplasty. In brief,
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1020the Surgisis patches are biologic material derived from
porcine small intestinal mucosa. The patches are composed
of cell-free collagen, which acts as a scaffold for host cell
deposition It was anticipated that these patches would
become replaced by the host’s native tissue and become
histologically identical to native artery.19
RESULTS
No complications related to the Surgisis patches were
noted until November 2002, when 7 patients were noted
to have asymptomatic pseudoaneurysms at follow-up du-
plex scanning performed 3 to 10 weeks postoperatively.
Four patients received covered stents. In 2 patients the
pseudoaneurysms were resected, with placement of inter-
position vein grafts. The last patient is being observed,
because the pseudoaneurysm is small and has remained
stable at 12 months of follow-up. The Surgisis patches were
immediately withdrawn from the market, and the adverse
events were reported to the US Food and Drug Adminis-
tration.
Detailed management in 1 of these patients was as
follows.
A 58-year-old man underwent uneventful CEA with
Surgisis patch angioplasty on November 16, 2002, to treat
a symptomatic severe stenosis of the carotid artery. On
December 6, 2002, he noted fullness in the neck. A duplex
scan confirmed the presence of a pseudoaneurysm contain-
ing thrombus.
A cerebral angiogram performed through a 5F catheter
placed in the right common femoral artery confirmed the
pseudoaneurysm (Fig 1). No intraluminal filling defects
were noted. Anticoagulation was achieved with 3000 units
of intravenous heparin, and weight-based ReoPro (Eli
Lilly) infusion was begun. The left internal carotid artery
was catheterized, with the 5F catheter advanced over a
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was placed distal to the pseudoaneurysm. An exchange
Rosen guide wire (Cook) was placed through the 5F cath-
eter, which was then removed. A 6  50-mm and a 6 
30-mm Wallgraft stent (Boston Scientific) were placed to
exclude the pseudoaneurysm, with overlapping of the
stents (Fig 2).
Post-stenting angiography demonstrated some con-
Fig 1. Cerebral angiogram reveals presence of large carotid pseu-
doaneurysm containing thrombus.
Fig 2. Cerebral angiogram shows successful exclusion of pseudo-
aneurysm with two stents.trast material leakage between the coaxial stents, which wastreated with balloon angioplasty with a 6-mm  2-cm
balloon (SDS, Boston Scientific) at the distal margin of the
stent and at the stent intersections. An 8-mm  2-cm
balloon was used at the proximal stent margin. Post-angio-
plasty angiography demonstrated no contrast leakage at the
proximal or distal stent margins or between the intersection
of the stents.
Dysarthria developed during the procedure. Cerebral
angiography demonstrated occlusion of the angular branch
of the left middle cerebral artery. Preparations were made
for lytic therapy. However, the neurologic deficit cleared,
and no lytic therapy was required. The ReoPro infusion was
continued for 12 hours postoperatively. The patient had no
further neurologic deficits.
A carotid duplex scan obtained before discharge dem-
onstrated thrombosis of the pseudoaneurysm, with a patent
stent. Clopidogrel (Plavix), 75 mg/d, was prescribed for 6
weeks, followed by maintenance aspirin therapy. However,
a carotid duplex scan at 12 months demonstrated an
asymptomatic occlusion of the Wallgraft.
Of the 3 additional patients treated with covered stents,
a transient ischemic attack (TIA) occurred in 1 patient
during deployment of the stent. Cerebral angiography
demonstrated thrombus in a branch of the middle cerebral
artery. This was lysed with thrombolytic therapy, with
resolution of the TIA. Wallgraft stents were used in all
patients. The other 2 patients had no neurologic events
during stent deployment. No cerebral protection devices
were used in any of these 4 patients. Carotid duplex imag-
ing after stent placement confirmed thrombosis of the
pseudoaneurysm and patent stents in all 4 patients. All were
given Clopidogrel for 6 weeks after stent placement, and
then maintenance aspirin therapy.
Follow-up. In only 1 patient did a 12-month follow-up
duplex scan demonstrate occlusion (asymptomatic) of the
stent. One patient died of cardiac causes several months after
treatment of the pseudoaneurysm, with no further neurologic
symptoms. The remaining 2 patients refused 12-month fol-
low-up duplex imaging, but both have had no neurologic
symptoms, per telephone interview.
DISCUSSION
In our practice we routinely patch the carotid artery
unless the internal carotid artery is large or CEA is confined
to the carotid bulb and proximal internal carotid artery. In
2001 we began using Surgisis patches in a clinical trial
approved by our institutional review board. Seventy-six
patients were enrolled. No problems related to the patches
were encountered until November 2002, when 7 patients
were found to have asymptomatic pseudoaneurysms. The
trial was immediately terminated, and the product was
withdrawn from the market. The detailed results of this trial
will be the subject of a separate publication. Because of the
considerable enthusiasm for endoluminal therapies in the
treatment of the wide variety of vascular disorders, we
believe that the sobering results in our 4 patients with
pseudoaneurysm treated with endoluminal covered stents
warranted a separate publication.
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with an interposition vein graft. This procedure was tech-
nically difficult because of the intense inflammatory
changes surrounding the carotid artery. It was not possible
to identify the suture line or any of the patch itself. In the
second patient who received a vein interposition graft the
common carotid artery was severely calcified, which pre-
cluded endoluminal therapy. At operation the suture line
was intact, and the entire patch was aneurysmal. Cultures
taken from these 2 patients were negative, and there were
no clinical signs or symptoms to suggest infection.
Because of the technical difficulties in these 2 pa-
tients treated surgically, we believed that endoluminal
treatment with covered stents was a reasonable option.
We thought that covered stents should be used, inas-
much as the patches, in essence, had dissolved, leaving a
large defect in the carotid artery. We elected to use
self-expandable Wallgraft stents. Use of covered stents,
bare metal stents, and vein-covered stents has been re-
ported in the literature.4-6,8-10,12,13 The results reported
Table I. Results of endoluminal therapy of carotid aneury
Authors
(first)
No. of
Patients Etiology Treatment moda
Bush9 5 Blunt trauma (3
patients) Post
CEA (2
patients)
Uncovered stents
coil embolizatio
of PSA
Lin6 1 Post CEA Covered stent
Smith8 1 Ruptured PSA due
to neuro-
fibromatosis
Covered stent
May4 1 Post CEA Covered stent
Duke16 6 Blunt trauma in all Uncovered stents
Coldwell17 14 Blunt trauma in all Uncovered stents
Horowitz13 2 Blunt trauma in all Uncovered stents
Huang14 1 Blunt trauma in all Uncovered stents
Matsuura15 1 Blunt trauma in all Uncovered stents
coil embolizatio
of PSA
Mericle12 1 Blunt trauma Uncovered stent a
coil embolizatio
Martin10 1 Hemorrhage from
carotid artery
necrosis
Bilateral vein-cove
stents
Singer11 1 Carotid aneurysm Covered stent
Hertz5 1 Post CEA Covered stent
PSA, Carotid artery pseudoaneurysms; CEA, carotid endarterectomy.in the literature are listed in the Table.Most series, ours included, include little long-term
follow-up data. The largest series was reported by Coldwell
et al.17 Their 14 patients with pseudoaneurysms secondary
to blunt trauma received bare stents and were prescribed
warfarin sodium therapy. All stents were patent at fol-
low-up angiography at a mean of 6 months.
In addition to deploying endoluminal stents to exclude
pseudoaneurysms, Bush et al9 embolized the pseudoaneu-
rysms by injecting coils through microcatheters through
the interstices of the stents. These authors also recom-
mended that the external carotid artery be embolized be-
fore stent placement if the pseudoaneurysm involves the
external carotid artery.6 We did not embolize the external
carotid artery in any of our 4 patients, and the pseudoan-
eurysms thrombosed in all, as documented on early post-
operative duplex scans.
Two of our 4 patients had a TIA secondary to emboli-
zation of thrombus from the pseudoaneurysm into
branches of the middle cerebral arteries, which was con-
firmed at angiography. In a case report by May et al4 the
or PSAs reported in the literature
Complications Length of follow-up
Coumadin
therapy after
stent
placement
1 patient had TIA
post procedure (no
details)
8.4 months (mean) 3
patients with patent
stents on
arteriography
No
None Patent by duplex at 18
months
No
None Patent by duplex scan
at 18 months
No
Stroke Occluded at 6 months Yes
None 4.6 months (mean) All
patent
Yes
None 6 months (mean) All
patent on
angiography
Yes
None Patent on angiography
at 3 months (both
cases)
No
None Patent on angiography
but no date
specified
No
None Patent at 1 year by
duplex scan
No
None No follow-up No
None 8 months - no
imaging studies
No
None 12 months - patent on
angiography
No
Died post-operatively
due to myocardial
infarction
—sms
lity
and
n
and
n
nd
n
redpatient had a stroke, and a computed tomography scan
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reported by Bush et al9 who received an endoluminal graft
a TIA occurred a few days after the procedure, but no
specific data were given.9 In none of the cases that we
reviewed were cerebral protection devices used. We did not
use them in our patients either, because we initially believed
the risk for cerebral embolization was low in the absence of
atherosclerotic disease. In addition, no filling defects were
noted on angiograms obtained before stent placement.
While we can not substantiate our opinion, we recommend
that cerebral protection devices be used in patients with
large pseudoaneurysms, because pseudoaneurysms that de-
velop after CEA are likely to contain a large amount of
thrombus.
The long-term patency of covered stents in the inter-
nal carotid artery is unknown; the series we reviewed
included only short-term follow-up data. In the only
patient in our series in whom we were able to obtain
12-month follow-up the stent graft was thrombosed. In
the patient reported by May et al4 the stent graft was
thrombosed at 6-month follow-up, despite the patient’s
taking warfarin sodium.4
In most reported cases uncovered stents were used. We
used covered stents in our 4 patients, because the defect in
the carotid artery involved the entire length of the arteriot-
omy. We believe that covered stents should be used if the
arterial defect is large, as in post-endarterectomy pseudo-
aneurysm, or in the case of true carotid aneurysm. Bare or
uncovered stents appear to be appropriate in pseudoaneu-
rysms in which the arterial defect is small, such as posttrau-
matic pseudoaneurysm. In such cases embolization of coils
into the pseudoaneurysm through the interstices of the
stent, as proposed by Bush et al,9 may be appropriate.
The role of anticoagulation therapy after stent place-
ment is speculative. We gave all of our patients Clopidogrel
for 6 weeks afterward, but admit that this was empiric.
Despite the absence of data to substantiate our opinion, we
think these patients should receive clopidogrel for 6 weeks
after stent graft placement, and should take warfarin so-
dium indefinitely.
CONCLUSION
While covered endoluminal stent grafts are effective in
excluding carotid pseudoaneurysms, their use is associated
with defininte risk for embolization. Cerebral protection
devices may be of benefit if imaging studies demonstrate
thrombus within the pseudoaneurysm. Concerns about the
long-term patency of these grafts in the carotid artery
position remain, and a word of caution appears appropriate.
Lifelong anticoagulation therapy with warfarin sodium may
be beneficial.REFERENCES
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